Shenzhen Cell Valley won the“Award Best Techology Breakthrough"in 2024
From April 2nd to 3rd, the fifth Asian Cell and Gene Therapy Innovation Summit of CGT Asia 2024 was successfully held in Shanghai. This summit brought together 6,616 professional guests from 2,539 well-known companies in 15 different countries to promote the industry. From the professional perspective of downstream integration and transformation of scientific and technological achievements, we conducted in-depth discussions on topics of high concern to industry experts such as the layout of cell therapy industrialization and commercialization modules, and the overcoming of viral vector application technologies, to jointly deeply empower the development of the industry.
Cell and gene therapy is a major strategic development direction of the country and the most promising research field for benefiting patients with intractable diseases worldwide. With the continuous innovation of technology and policy support, the cell and gene therapy industry continues to grow and the industry is gradually entering a golden period. Strengthening original and leading research and tackling key core technologies will become a vital accelerator for the development of the industry.
Shenzhen Cell Valley will rely on its profound technical background, leading scientific research strength and unremitting pioneering spirit to continuously strengthen the synergy between industry, academia, research and application, promote the transformation of research results and clinical application, and jointly promote the comprehensive development of IIT Clinical Cell Therapy Center with domestic and international medical institutions, create a new model of precision medicine treatment, and make greater contributions to human health.